Cover Image
市場調查報告書

內分泌檢查的全球市場:2015年∼2019年

Global Endocrine Testing Market 2015-2019

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 332633
出版日期 內容資訊 英文 101 Pages
訂單完成後即時交付
價格
Back to Top
內分泌檢查的全球市場:2015年∼2019年 Global Endocrine Testing Market 2015-2019
出版日期: 2015年06月10日 內容資訊: 英文 101 Pages
簡介

全球內分泌檢查市場預測在2014年∼2019年這段期間將以4.66%的速度成長。

本報告提供全球內分泌檢查市場相關之調查分析,提供您市場規模與成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,並彙整主要供應商等相關的系統性資訊。

第1章 摘要整理

第2章 簡稱清單

第3章 調查範圍

  • 市場概要
  • 提供產品

第4章 市場調查手法

  • 市場調查流程
  • 調查手法

第5章 簡介

第6章 市場形勢

  • 市場概要
  • 市場規模·預測
  • 波特的五力分析

第7章 市場區隔:檢查別

第8章 市場區隔:診斷各技術

  • 全球臨床化學技術市場
  • 全球免疫檢測技術市場
  • 全球單克隆·多株抗體技術市場
  • 全球串聯式質譜分析技術市場
  • 全球感應技術市場

第9章 地區區分

  • 南北美洲的內分泌檢查市場
  • EMEA (歐洲·中東·非洲) 的內分泌檢查市場
  • APAC (亞太地區) 的內分泌檢查市場

第10章 購買標準

第11章 推動市場成長要素

第12章 成長推動因素與其影響

第13章 市場課題

第14章 成長推動因素與課題的影響

第15章 市場趨勢

第16章 趨勢與其影響

第17章 業者情勢

  • 競爭情形
  • 市場佔有率分析
  • 其他有潛力的供應商

第18章 主要供應商分析

  • Abbott Diagnostics
    • 主要資料
    • 產業概要
    • 地理存在感
    • SWOT分析
  • DiaSorin
  • Roche Diagnostics
  • Siemens Healthcare Diagnostics
  • Thermo Fisher Scientific

第19章 相關報告

圖表

目錄
Product Code: IRTNTR6125

About Endocrine Testing Systems

Endocrine testing system refers to a collection of tests that involve all the glands of the body and the hormones produced by those glands. The endocrine system together with nervous system regulates and controls many internal body functions. While the endocrine system uses chemical messengers called hormones, the nervous system uses nerve impulses as a means of control. The endocrine system plays a role in reproduction, growth and sexual development, responses to injury and stress, body energy levels, bone and muscle strength, and internal balance of the body.

Technavio's analysts forecast the global endocrine testing market to grow at a CAGR of 4.66% over the period 2014-2019.

Covered in this Report

In this report, Technavio covers the present scenario and the growth prospects of the global endocrine testing market for the period 2015-2019. To calculate the market size, we consider the revenue generated from the sales of the products (instruments and reagents) used in the following endocrine testing technologies:

  • Types of Diagnostic Technologies
  • Clinical chemistry technologies
  • Immunoassay technologies
  • Tandem mass spectrometry
  • Monoclonal and polyclonal antibodies
  • Sensor technologies
  • Others

The report also provides information about the following endocrine tests:

  • FSH
  • TSH
  • hCG
  • DHEAS
  • Progesterone
  • Testosterone
  • Insulin
  • Prolactin
  • Cortisol
  • Estradiol
  • Luteinizing Hormone

This report covers the present scenario and the growth prospects of the endocrine testing market for the period 2015-2019 mainly for three regions:

  • Americas: The principal countries in the Americas are the US, Canada, Mexico, and Brazil.
  • EMEA: The principal countries focused in this region are the UK, Germany, Italy, France, Spain, Israel, South Africa, Egypt, Sudan, Kuwait, Saudi Arabia, Qatar, and UAE.
  • APAC: The principal countries focused in this region are Japan, China, Australia, Singapore, South Korea, and India.

Technavio's report, Global Endocrine Testing Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • APAC
  • EMEA

Key Vendors

  • Abbott Diagnostics
  • Diascorin
  • Roche Diagnostics
  • Siemens Healthcare
  • Thermo Fisher Scientific

Other Prominent Vendor

  • AdnaGen
  • Alere
  • Allele Biotechnology
  • Axis-Shield
  • Beckman Coulter/Danaher
  • Biomedical Diagnostics
  • BioMerieux
  • Bio-Rad
  • Diametra
  • Enzo Life Sciences
  • Fujirebio
  • ImmunoDX
  • Immunonodiagnostics System
  • InDevR
  • Innogenetics
  • Kyowa Medex
  • Merck Millipore
  • Meridian Bioscience
  • Meso Scale Discovery
  • NanoEnTek
  • Nova Century Scientific
  • Ortho-Clinical Diagnostics
  • Quidel
  • Randox
  • SDIX
  • Sysmex
  • Tecan
  • Tosoh Bioscience
  • Vital Diagnostics
  • ZEUS Scientific

Market Driver

  • Growing Aging Population
  • For a full, detailed list, view our report

Market Challenge

  • Limited Detection and Complexity of Immunoassays
  • For a full, detailed list, view our report

Market Trend

  • Automation and System Integration
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. Five Forces Analysis

07. Market Segmentation by Tests

08. Market Segmentation by Diagnostic Technology

  • 08.1. Global Clinical Chemistry Technology Market
    • 08.1.1. Market Size and Forecast
  • 08.2. Global Immunoassay Technology Market
    • 08.2.1. Market Size and Forecast
  • 08.3. Global Monoclonal and Polyclonal Antibodies Technology Market
    • 08.3.1. Market Size and Forecast
  • 08.4. Global Tandem Mass Spectrometry Technology Market
    • 08.4.1. Market Size and Forecast
  • 08.5. Global Sensor Technology Market
    • 08.5.1. Market Size and Forecast

09. Geographical Segmentation

  • 09.1. Endocrine Testing Market in Americas
    • 09.1.1. Market Size and Forecast
  • 09.2. Endocrine Testing Market in EMEA
    • 09.2.1. Market Size and Forecast
  • 09.3. Endocrine Testing Market in APAC
    • 09.3.1. Market Size and Forecast

10. Buying Criteria

11. Market Growth Drivers

12. Drivers and their Impact

13. Market Challenges

14. Impact of Drivers and Challenges

15. Market Trends

16. Trends and their Impact

17. Vendor Landscape

  • 17.1. Competitive Scenario
    • 17.1.1. Key News
    • 17.1.2. Mergers and Acquisitions
  • 17.2. Market Share Analysis 2014
    • 17.2.1. Abbott
    • 17.2.2. DiaSorin
    • 17.2.3. Roche
    • 17.2.4. Siemens Healthcare
    • 17.2.5. Thermo Fisher
  • 17.3. Other Prominent Vendors

18. Key Vendor Analysis

  • 18.1. Abbott Diagnostics
    • 18.1.1. Key Facts
    • 18.1.2. Business Overview
    • 18.1.3. Geographical Presence
    • 18.1.4. SWOT Analysis
  • 18.2. DiaSorin
    • 18.2.1. Key Facts
    • 18.2.2. Business Overview
    • 18.2.3. Business Segmentation by Revenue 2013
    • 18.2.4. Business Segmentation by Revenue 2012 and 2013
    • 18.2.5. Geographical Segmentation by Revenue 2013
    • 18.2.6. Business Strategy
    • 18.2.7. Recent Developments
    • 18.2.8. SWOT Analysis
  • 18.3. Roche Diagnostics
    • 18.3.1. Key Facts
    • 18.3.2. Business Overview
    • 18.3.3. Business Segmentation by Revenue 2014
    • 18.3.4. Business Segmentation by Revenue 2013 and 2014
    • 18.3.5. Geographical Segmentation by Revenue 2014
    • 18.3.6. Business Strategy
    • 18.3.7. Recent Developments
    • 18.3.8. SWOT Analysis
  • 18.4. Siemens Healthcare Diagnostics
    • 18.4.1. Key Facts
    • 18.4.2. Business Overview
    • 18.4.3. SWOT Analysis
  • 18.5. Thermo Fisher Scientific
    • 18.5.1. Key Facts
    • 18.5.2. Business Overview
    • 18.5.3. Business Segmentation by Revenue 2014
    • 18.5.4. Business Segmentation by Revenue 2013 and 2014
    • 18.5.5. Geographical Segmentation by Revenue 2014
    • 18.5.6. Business Strategy
    • 18.5.7. Recent Developments
    • 18.5.8. SWOT Analysis

19. Other Reports in this Series

List of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Snapshot of Global Endocrine Testing Market 2014-2019
  • Exhibit 3: Global Endocrine Testing Market 2014-2019 ($ millions)
  • Exhibit 4: Global Endocrine Testing Market Segmentation by Type of Tests
  • Exhibit 5: Global Endocrine Testing Market Segmentation by Type of Tests 2014
  • Exhibit 6: Normal FSH Level (depends on age and gender)
  • Exhibit 7: TSH Standard Reference Levels
  • Exhibit 8: TSH Levels during Pregnancy
  • Exhibit 9: hCG Levels in Early Pregnancy
  • Exhibit 10: DHEAS Levels
  • Exhibit 11: Progesterone Levels During Different Phases of the Menopause Cycle and Pregnancy
  • Exhibit 12: Normal Levels of Testosterone
  • Exhibit 13: Glucose Levels
  • Exhibit 14: Standard Levels of Prolactin
  • Exhibit 15: Normal Cortisol Levels
  • Exhibit 16: Normal Estradiol Levels
  • Exhibit 17: Normal LH Levels
  • Exhibit 18: Segmentation of Global Endocrine Testing Market by Type of Diagnostic Technology
  • Exhibit 19: Segmentation of Global Endocrine Testing Market by Technology 2014
  • Exhibit 20: Global Clinical Chemistry Technology Market 2014-2019 ($ millions)
  • Exhibit 21: Global Immunoassay Technology Market 2014-2019 ($ millions)
  • Exhibit 22: Global Monoclonal and Polyclonal Antibodies Technology Market 2014-2019 ($ millions)
  • Exhibit 23: Global Tandem Mass Spectrometry Technology Market 2014-2019 ($ millions)
  • Exhibit 24: Global Sensor Technology Market 2014-2019 ($ millions)
  • Exhibit 25: Global Endocrine Testing Market Segmentation Analysis 2014-2019
  • Exhibit 26: Segmentation of Global Endocrine Testing Market by Type of Technology 2014-2019
  • Exhibit 27: Global Endocrine Testing Market by Geographical Segmentation 2014
  • Exhibit 28: Endocrine Testing Market in Americas 2014-2019 ($ millions)
  • Exhibit 29: Endocrine Testing Market in EMEA 2014-2019 ($ millions)
  • Exhibit 30: Endocrine Testing Market in EMEA 2014-2019 ($ millions)
  • Exhibit 31: Global Endocrine Testing Market by Geography 2014-2019 in ($ millions)
  • Exhibit 32: Global Endocrine Testing Market by Geography 2014-2019
  • Exhibit 33: Percentage of Elderly Aged above 65 in Different Regions 2012 and 2050
  • Exhibit 34: Estimated Percentage of Elderly Population 2012 and 2050
  • Exhibit 35: Abbott: Key Takeaways
  • Exhibit 36: DiaSorin: Revenue by Technology 2014
  • Exhibit 37: DiaSorin: Key Takeaways
  • Exhibit 38: Roche: Key Takeaways
  • Exhibit 39: Siemens Healthcare: Key Takeaways
  • Exhibit 40: Thermo Fisher: Key Takeaways
  • Exhibit 41: Abbott Diagnostics: Geographical Presence
  • Exhibit 42: DiaSorin: Business Segmentation by Revenue 2013
  • Exhibit 43: DiaSorin: Business Segmentation by Revenue 2012 and 2013 (US$ million)
  • Exhibit 44: DiaSorin: Geographical Segmentation by Revenue 2013
  • Exhibit 45: Roche Diagnostics: Business Segmentation by Revenue 2014
  • Exhibit 46: Roche Diagnostics: Business Segmentation by Revenue 2013 and 2014 ($ billion)
  • Exhibit 47: Roche Diagnostics: Geographical Segmentation by Revenue 2014
  • Exhibit 48: Thermo Fisher Scientific: Business Segmentation by Revenue 2014
  • Exhibit 49: Thermo Fisher Scientific: Business Segmentation by Revenue 2013 and 2014 ($ billion)
  • Exhibit 50: Thermo Fisher Scientific: Geographical Segmentation by Revenue 2014
Back to Top